Form 4: Zimmer Biomet Executive Rachel Ellingson Reports Stock Transactions

Rachel Ellingson, Chief Administrative Officer of Zimmer Biomet, reports the vesting of restricted stock units and subsequent tax withholding.

Summary

• On February 20, 2025, Rachel Ellingson, Chief Administrative Officer of Zimmer Biomet Holdings, Inc., had restricted stock units (RSUs) vest.
• A total of 1,566 shares of common stock were acquired upon the vesting of these RSUs.
• 491 shares were withheld by the company to cover tax obligations related to the vesting.
• The price per share for the tax withholding was $103.46.
• Following these transactions, Ellingson directly owns 11,906 shares of Zimmer Biomet common stock and 3,131 restricted stock units.
• One-third of the RSUs vested on February 20, 2025, with the remainder vesting in two equal installments on February 20, 2026, and February 20, 2027.

Sentiment

Score: 5

Explanation: This is a neutral report on stock transactions related to executive compensation. It doesn't indicate positive or negative performance for the company.

Future Outlook

The remaining RSUs will vest in two equal installments on February 20, 2026, and February 20, 2027.

Industry Context

This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The transaction has a minor impact on the total outstanding shares of Zimmer Biomet.

Key Dates